That is to say, a free drug concentration of maprotiline in vivo is about 100 nM, which is equivalent with the KD value for maprotiline binding to sGC in vitro and hence gives some hope that maprotiline could be effective for human PAH. This evidence concerns the gene SGCB and pulmonary arterial hypertension.